RT

Rohan Tomar

Active Director Director DIN 08895485
DIN 08895485 First appointment Sep 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Rohan Tomar

Data last updated:

Rohan Tomar is a Director at Sickcure Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Sickcure Pharmaceuticals Private Limited reported revenue of ₹73.6 Lakh (FY 2024).

DIN 08895485
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2020
Oldest Company Age 6 yrs
Largest company Sickcure Pharmaceuticals Private Limited · ₹73.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Sep 20202020₹73.6 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Sickcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rohan Tomar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohan Tomar

Rohan Tomar currently holds 1 directorship: Sickcure Pharmaceuticals Private Limited (Director, since 26 Sep 2020, revenue ₹73.6 Lakh (FY 2024)).

Rohan Tomar was first appointed on 26 Sep 2020 as Director at Sickcure Pharmaceuticals Private Limited.

The current boards of Rohan Tomar's companies include Jagdish Kumar (Sickcure Pharmaceuticals Private Limited), Madhumita Baidya (Sickcure Pharmaceuticals Private Limited), Netar Singh Chauhan (Sickcure Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available